Hepatocellular carcinoma cell-derived small extracellular vesicle-associated CD147 serves as a diagnostic marker and promotes endothelial cell angiogenesis via the PI3K/Akt pathway

Abstract

Aim: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. The process of HCC development is closely related to angiogenesis. Plasma exosomes have diagnostic value in many diseases and have become a current research hotspot. We aimed to identify a key molecule in small extracellular vesicles (sEVs) involved in angiogenesis as a diagnostic marker for HCC and uncover the mechanism underlying its regulation in the angiogenesis process.

Methods: Nano‐flow cytometer (nFCM) was used to detect CD147 expression in plasma-derived sEVs in 155 HCC patients, 59 liver cirrhosis (LC), and 82 healthy donors (HD). The mechanism of hepatocellular carcinoma cell-derived sEVs CD147 promoting angiogenesis was elucidated by cell proliferation assay, scratch wound healing assay, transwell assay, tube formation assay, and in vivo Matrigel plug angiogenesis assay.

Results: We found that CD147 expression was significantly higher in HCC tissue samples than in normal tissues. We also found a significantly larger number of CD147-positive small extracellular vesicles (CD147⁺ sEVs) in the plasma of HCC patients than LC patients and HD. Furthermore, we showed that hepatocellular carcinoma cell (HepG2)-derived CD147⁺ sEVs promoted cell proliferation, migration, invasion, and angiogenesis in human umbilical vein endothelial cells. The CD147⁺ sEVs upregulated vascular endothelial growth factor A (VEGFA) by activating the PI3K/Akt pathway, thereby promoting angiogenesis.

Conclusion: HCC-derived sEVs-associated CD147 serves as a diagnostic marker and promotes endothelial cell angiogenesis via the PI3K/Akt pathway.

Keywords

Hepatocellular carcinoma / small extracellular vesicles / CD147 / diagnosis / angiogenesis

References

[1] Omata M,Kokudo N.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Hepatol Int2017;11:317-70. PMCID:PMC5491694

[2] Marrero JA,Sirlin CB.Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the american association for the study of liver diseases.Hepatology2018;68:723-50

[3] Llovet JM,Villanueva A.Hepatocellular carcinoma.Nat Rev Dis Primers2021;7:6

[4] Benson AB 3rd,Abbott DE.NCCN guidelines insights: hepatobiliary cancers, version 1.2017.J Natl Compr Canc Netw2017;15:563-73 PMCID:PMC5557008

[5] Benson AB,Abbott DE.NCCN guidelines insights: hepatobiliary cancers, version 2.2019.J Natl Compr Canc Netw2019;17:302-10.

[6] Maluccio M.Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma.CA Cancer J Clin2012;62:394-9

[7] Lee YT,Wang JJ.The role of extracellular vesicles in disease progression and detection of hepatocellular carcinoma.Cancers2021;13:3076. PMCID:PMC8233859

[8] Rao D,Sang C,Zhang Z.Advances in mesenchymal stem cell-derived exosomes as drug delivery vehicles.Front Bioeng Biotechnol2021;9:797359 PMCID:PMC8854766

[9] Théry C,Aikawa E.Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.J Extracell Vesicles2018;7:1535750 PMCID:PMC6322352

[10] Huang D,Hu D.Advances in biological function and clinical application of small extracellular vesicle membrane proteins.Front Oncol2021;11:675940 PMCID:PMC8172959

[11] Huang M,Zhong Y.New insights into the regulatory roles of extracellular vesicles in tumor angiogenesis and their clinical implications.Front Cell Dev Biol2021;9:791882 PMCID:PMC8710745

[12] Landras A,Jouenne F,Menashi S.CD147 is a promising target of tumor progression and a prognostic biomarker.Cancers2019;11:1803 PMCID:PMC6896083

[13] Peng F,You Q.CD147 as a novel prognostic biomarker for hepatocellular carcinoma: a meta-analysis.Biomed Res Int2017;2017:5019367 PMCID:PMC5366185

[14] Bougatef F,Kellouche S.EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2.Blood2009;114:5547-56

[15] Tang Y,Kesavan P.Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.Cancer Res2005;65:3193-9

[16] Millimaggi D,D'Ascenzo S.Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells.Neoplasia2007;9:349-57. PMCID:PMC1854851

[17] Belton RJ Jr,Mesquita FS.Basigin-2 is a cell surface receptor for soluble basigin ligand.J Biol Chem2008;283:17805-14 PMCID:PMC2440618

[18] Tang Y,Rafferty P.Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.Mol Cancer Res2006;4:371-7

[19] Knutti N,Friedrich K.Soluble extracellular matrix metalloproteinase inducer (EMMPRIN, EMN) regulates cancer-related cellular functions by homotypic interactions with surface CD147.FEBS J2015;282:4187-200

[20] Théry C,Raposo G.Isolation and characterization of exosomes from cell culture supernatants and biological fluids.Curr Protoc Cell Biol2006;Chapter 3:Unit 3.22

[21] Wu J,Zhang Y.HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.Oncogene2011;30:4410-27

[22] Grass GD,Toole BP.Regulation of invadopodia formation and activity by CD147.J Cell Sci2012;125:777-88 PMCID:PMC3367836

[23] Caudroy S,Nawrocki-Raby B.EMMPRIN-mediated MMP regulation in tumor and endothelial cells.Clin Exp Metastasis2002;19:697-702.

[24] Montal R,Bassaganyas L.Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials.Br J Cancer2019;121:340-3 PMCID:PMC6738090

[25] Galle PR,Kudo M.Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.Liver Int2019;39:2214-29

[26] Qin LX.Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.J Cancer Res Clin Oncol2004;130:497-513

[27] Farinati F,De Giorgio M.Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?.Am J Gastroenterol2006;101:524-32

[28] Said NA,Socha MJ,Mok SC.SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk.Neoplasia2007;9:23-35. PMCID:PMC1803033

[29] Zechmann CM,Brix G.Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors.Neoplasia2007;9:57-67 PMCID:PMC1803035

[30] Wang L,Yu L.Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference.Cancer Biol Ther2006;5:608-14

[31] Jiang BH.AKT signaling in regulating angiogenesis.Curr Cancer Drug Targets2008;8:19-26

[32] Hamada K,Koni PA.The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis.Genes Dev2005;19:2054-65. PMCID:PMC1199575

[33] Hu L,Jaffe RB.Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma.Clin Cancer Res2005;11:8208-12